Global Human Rabies Immunoglobulin (IM) market is forecast to 510 million US in 2025
In 2017, the global Human Rabies Immunoglobulin (IM) market size was 290 million US$ and is forecast to 510 million US in 2025, growing at a CAGR of 7.6% from 2018. https://www.qyresearch.com/index/detail/736723/global-human-rabies-immunoglobulin-im-market
In 2017, the global Human Rabies Immunoglobulin (IM) market size was 290 million US$ and is forecast to 510 million US in 2025, growing at a CAGR of 7.6% from 2018.
https://www.qyresearch.com/index/detail/736723/global-human-rabies-immunoglobulin-im-market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
QYResearch<br />
• The classification accord<strong>in</strong>g <strong>to</strong> the material of <strong>Human</strong> <strong>Rabies</strong><br />
<strong>Immunoglobul<strong>in</strong></strong> (<strong>IM</strong>) <strong>in</strong>cludes ERIG, HRIG, and the<br />
proportion of HRIG <strong>in</strong> 2017<strong>is</strong> about 86.7%, and the<br />
proportion <strong>is</strong> <strong>in</strong> <strong>in</strong>creas<strong>in</strong>g trend from 2013 <strong>to</strong> 2017.<br />
• For ERIGs, the dosage <strong>is</strong> 40 IU per kg body weight subject<br />
<strong>to</strong> a maximum of 3000 IU. For HRIGs, the dosage <strong>is</strong> 20 IU<br />
per kg body weight subject <strong>to</strong> a maximum of 1500 IU.<br />
www.qyresearch.com
Change language